Early-stage diagnosis of Alzheimer’s disease.
Bottneuro has raised €4.2M across 2 funding rounds from 4 investors, most recently a round in Dec 2022. Based in Basel, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-12-15 | Other | €4.1M | DART Labs ,Hemex,Zühlke Ventures | View deal → |
| 2021-12-20 | Other | €144k | Venture Kick | View deal → |
